5 February 2020
Dr Mike Linney, Registrar and Chair of the Ethics Committee for RCPCH, welcomes recent guidance from NICE, but notes the urgent need for high quality, independent research on this medicine to provide the best possible care for children with complex epilepsy.
31 January 2020
The review was commissioned by the Chief Executive of NHS England to assist its Board in the evaluation of responses to a consultation undertaken in summer 2019 relating to a new draft service specification for children’s cancers.
28 January 2020
A joint report by RCPCH and the Royal College of Physicians suggests we need to do more to improve the quality of our indoor air.
16 January 2020
Our President Professor Russell Viner comments on the Dubs amendment to protect child refugees from family separations.
16 December 2019
Domperidone is no longer licensed for use in children younger than 12 years or those weighing less than 35 kg because of a lack of evidence for benefit.
10 December 2019
We're delighted to announce this year's winner of the RCPCH Global Programme Development Grant. Korle Bu Teaching Hospital (KBTH)'s one-year programme is identifying gaps in the quality of post-discharge care and how to make improvements and scale up, despite limited resources.
25 October 2019
Next year’s RCPCH Conference will play host to a diverse line-up of prominent speakers who will take to the main stage over the three-day event.
16 October 2019
Withdrawal and Medicines Alerts for Ranitidine Related Products Zantac®, used to treat conditions such as acid reflux in children, has been recalled by its manufacturer because of concerns that it may contain low levels of NDMA.
25 September 2019
The Scottish Health Survey (SHeS) provides a detailed picture of the health of the Scottish population in private households and is designed to make a major contribution to the monitoring of health in Scotland. RCPCH Officer for Scotland, Professor Steve Turner, responds.
13 August 2019
Last week, NICE published draft recommendations on the use of cannabis-based medicinal products (CBMPs) following evaluation of their clinical and cost-effectiveness, and NHS England published a review aimed at assessing the barriers to prescribing cannabis-based medicinal products where it is safe ...